Phosphodiesterase 7 inhibitor reduced cognitive impairment and pathological hallmarks in a mouse model of Alzheimer's disease
Rocío Pérez‐González(Nathan Kline Institute for Psychiatric Research), Eva Carro(Instituto de Salud Carlos III), Isidró Ferrer(Bellvitge University Hospital), Ana Martı́nez(Consejo Superior de Investigaciones Científicas), Agnieszka Krzyzanowska(Research Institute Hospital 12 de Octubre), Marta Bolós(Biomedical Research Networking Center on Neurodegenerative Diseases), Carmen Gil(Instituto de Salud Carlos III), Consuelo Pascual(Research Institute Hospital 12 de Octubre), Desireé Antequera(Instituto de Salud Carlos III), Manuel Sarasa(Universidad de Zaragoza), Virginia Pérez‐Grijalba, Miriam Redondo(Instituto de Química Médica), Daniel I. Pérez(Cedars-Sinai Medical Center)
Cited by 90
Related Papers
Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions
|Nature Genetics|2010|608
Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy
|Acta Neuropathologica|2015|528
Staging of Neurofibrillary Pathology in Alzheimer's Disease: A Study of the BrainNet Europe Consortium
|Brain Pathology|2008|479
COVID-19: Drug Targets and Potential Treatments
|Journal of Medicinal Chemistry|2020|469